Navigation Links
Taking Control: Future Therapies for a Host of Serious Diseases May Be Found in Women's Menstrual Blood
Date:7/7/2008

C'elle Enables Women to Easily Collect and Preserve Vital Stem Cells During Their Menstrual Flow; Potential for Future Anti-Aging and Sports Medicine

Therapies

OLDSMAR, Fla., July 7 /PRNewswire-FirstCall/ -- With today's hectic lifestyle, where most women are juggling careers, family, relationships, and a host of activities, the idea of possibly facing a serious illness in the future is not something that readily comes to mind -- especially when a woman is in the prime of her life. But what most women don't know, is that the key to treating a number of possibly life-threatening diseases that she, a parent, a sibling or even her children may face in later years, such as osteoporosis, heart disease, stroke, Alzheimer's and Parkinson's disease, may be found within her own body -- in vital stem cells, which can now be harvested from her own menstrual blood.

Now, thanks to the revolutionary research and technology of C'elle, a service dedicated to providing women with a safe and easy method of collecting and preserving stem cells found in her menstrual fluid each month, even the busiest woman can take control of her future, right in the privacy of her own home. With C'elle's non-invasive collection process, menstrual cells are processed and cryo-preserved (stored at a very low temperature) for potential cellular therapies that may be used in the future. These self-renewing cells one day may even be used for sports medicine or cosmeceutical treatments, such as anti-aging therapies.

"C'elle enables and empowers a woman to take control of her future health, and possibly of those genetically closest to her, in a fast, painless and stress free way," said Michelle Kay, Marketing and Sales Manager for C'elle. "We live in exciting times, as science and technology are discovering how extremely valuable menstrual blood stem cells really are, and the enormous treatment potential they represent for future therapies. C'elle's ongoing research is supporting these promising findings."

For more information about C'elle, please call 1-877-892-3553 or visit http://www.celle.com.

About Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL)

Based in Oldsmar, Florida, with over 150,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the-art Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded company. OTC Bulletin Board Symbol: CCEL. For more information, please call 1-800-STOR-CELL (1-800-786-7235) or visit http://www.cryo-cell.com.

Media Contact:

Debbie Koke

(914) 536-7557

Debbie@horizonmarketing.com


'/>"/>
SOURCE Cryo-Cell International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Depression Taking Toll on Returning U.S. Vets
2. 13 percent of women stop taking breast cancer drug because of side effects, U-M study finds
3. Study finds drug spending caps cause some seniors to quit taking key medicines
4. The Nutrition-Conscious Are Taking a Bite Out of Fast Food
5. New Resource for Taking Care of Aging Parents Available in Beta
6. Study finds drug spending caps cause some seniors to quit taking key medicines
7. Blue Cross And Blue Shield Association Survey Shows Consumer Driven Health Plan Enrollees Are Taking More Control of Their Healthcare
8. Taking the stress out of choosing the right stress test
9. Better Prostate Cancer Survival for Men Taking Statins
10. Multi-talented Entertainer Chris Brown Goes Back to School, Taking on a Starring Role in the St. Jude Math-A-Thon (R) Video
11. Mayo Clinic study finds that after heart attack most patients stop taking life-saving drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... ... University, has officially announced the appointment of Peter A. Bell, DO, MBA, HPF, ... Medicine (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... hearing disabilities, it is so critically important that we all are aware of ... is why Mediaplanet is proud to announce the launch of its newest edition ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... With ProGlass ... Cut Pro X . Users have total control over position, rotation, distortion, edge softness, ... all within Final Cut Pro X. , With ProGlass Prism users are given the ...
(Date:2/24/2017)... ... ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 top five ... art competition. Selected from 15 submissions from around the nation, the top five finalists ... iaedp Symposium, March 22 – 26 in Las Vegas. , This year, the competition ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... specializes in thought leadership , media relations, social media, content marketing and ... will be powered through Act-On, an intuitive marketing automation platform. , Rosica will ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)...  This report analyzes the worldwide markets for Chiral ... Products: Intermediates, Analytical, and Others. The End Use ... Agrochemicals. The report provides separate comprehensive analytics for the ... , and Rest of World. Annual estimates and ... Also, a six-year historic analysis is provided for these ...
(Date:2/24/2017)... -- Medivir AB (Nasdaq Stockholm: MVIR) today ... of Directors that will be submitted to the 2017 ... of the company,s three largest shareholders at the end ... a seat on the Nomination Committee, and the Chairman ... Committee was as follows:  ...
(Date:2/23/2017)... Visiomed, the French leader in medical ... changing the landscape of healthcare with their innovative ... custom-made solutions. Recognizing the rising demand of self-monitoring ... without walls, Visiomed has launched BewellConnect, the most ... professionals that is empowering the lives of patients. ...
Breaking Medicine Technology: